Multiple Signals in the Gut Contract the Mouse Norovirus Capsid To Block Antibody Binding While Enhancing Receptor

Alexis N Williams1, Michael B Sherman1, Hong Q Smith1

  • 1University of Texas Medical Branch at Galveston, Department of Biochemistry and Molecular Biology, Galveston, Texas, USA.

Journal of Virology
|September 1, 2021
PubMed

Insights

Low pH, bile, and metals trigger mouse norovirus capsid changes, blocking antibody binding and priming for cell entry. These findings are crucial for understanding norovirus infection and developing treatments.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • Human norovirus causes widespread gastroenteritis, lacking vaccines or antivirals.
  • Noroviruses possess icosahedral capsids with protruding (P) domains for receptor and antibody interaction.
  • Previous work showed bile binding induces conformational changes in mouse norovirus (MNV) capsids.

Purpose of the Study:

  • To investigate the effect of low pH on MNV capsid conformation.
  • To determine if low pH induces similar conformational changes as bile binding.
  • To understand the role of acidic residues and metals in pH-mediated conformational changes.

Main Methods:

  • Near-atomic cryo-electron microscopy of MNV at pH 5.0 and pH 7.5.
  • Enzyme-linked immunosorbent assays (ELISAs) with infectious virus particles.
  • Analysis of conformational changes induced by low pH and metal binding.

Main Results:

  • Low pH (5.0) induced conformational changes in MNV capsids nearly identical to those caused by bile.
  • A cluster of acidic residues in the G'-H' loop likely drives these pH-dependent conformational changes.
  • Low pH and cationic metals blocked antibody binding to the MNV capsid.

Conclusions:

  • Low pH, bile salts, and cationic metals act synergistically as physiological triggers in the gut.
  • These triggers induce P domain contraction and structural rearrangement, facilitating receptor binding.
  • The conformational changes prime the virus for infection while simultaneously blocking antibody recognition.

Related Concept Videos